WOLF CREEK, MT / ACCESSWIRE / August 8, 2023 / Solo-Dex, a leading innovator in the healthcare technology industry, is proud to announce its nomination for the esteemed 2023 Prix Galien USA Awards. The Galien Foundation has recognized our significant contributions in the "Best Medical Technology" category.
Solo-Dex's ground-breaking non-opioid acute pain management product has demonstrated remarkable innovation in the world of medical technology, enhancing the quality of patient care while maximizing efficiency in treatment strategies.
The Prix Galien USA Awards, bestowed by The Galien Foundation, honor outstanding achievements in improving the human condition through the development of innovative therapies and technologies. The award recognizes leading companies that have introduced significant technological, scientific, or solution-driven breakthroughs in healthcare.
"We are honored to be nominated by The Galien Foundation, and we consider it a demonstration of our commitment to innovate and improve the healthcare landscape with our unique medical technology solutions," said Steven Eror, CEO of Solo-Dex, Inc. "We share this accomplishment with our dedicated team and our valued customers and shareholders who continuously support our mission to manage pain without the use of opioids and to reduce cognitive impairment that may be associated with general anesthesia in seniors. "
The winners of the Prix Galien USA 2023 will be announced later this year at a ceremony in New York City. Regardless of the outcome, being a nominee already places Solo-Dex amongst the very best in our industry and serves as a validation of our persistent efforts to shape the future of healthcare.
"We want to thank our clients, shareholders, and investors for your continued support. Our nomination signifies that we are making impactful strides within the digital healthcare industry. We look forward to continuing our work, creating innovative solutions, and contributing to a healthier future," added Mr. Eror.
To learn more about the Prix Galien USA 2023 nominees, visit https://www.galienfoundation.org/prix-galien-usa
About Solo-Dex, Inc.
Solo-Dex Corporation is a leading healthcare technology company dedicated to improving patient care through innovative medical technology solutions. Our product line is focused on enhancing the quality and efficiency of non-opioid acute pain management, making a significant difference in the lives of patients and practitioners alike.
Investors and Media:
Solo-Dex, Inc.
1576 MT Highway 434
Wolf Creek, MT 59648
Office: (801) 631-7288
Email: [email protected]
Website: www.solo-dex.com
SOURCE: Solo-Dex, Inc.